Cohlhepp Ryan
President and COO · 38 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-09 | BCAX | Bicara Therapeutics Inc. | Sale | 536 | $29.00 | $15,544.00 | filing |
| 2026-07-08 | BCAX | Bicara Therapeutics Inc. | Sale | 22,833 | $28.76 | $656,651.96 | filing |
| 2026-07-08 | BCAX | Bicara Therapeutics Inc. | Sale | 4,306 | $29.80 | $128,302.01 | filing |
| 2026-07-08 | BCAX | Bicara Therapeutics Inc. | Option exercise | 18,750 | $3.79 | $71,058.75 | filing |
| 2026-07-08 | BCAX | Bicara Therapeutics Inc. | Sale | 1,075 | $30.35 | $32,631.52 | filing |
| 2026-05-15 | BCAX | Bicara Therapeutics Inc. | Sale | 8,000 | $20.29 | $162,335.20 | filing |
| 2026-05-15 | BCAX | Bicara Therapeutics Inc. | Sale | 4,500 | $20.29 | $91,313.55 | filing |
| 2026-05-15 | BCAX | Bicara Therapeutics Inc. | Option exercise | 8,000 | $3.79 | $30,318.40 | filing |
| 2026-04-15 | BCAX | Bicara Therapeutics Inc. | Sale | 8,000 | $23.01 | $184,058.40 | filing |
| 2026-04-15 | BCAX | Bicara Therapeutics Inc. | Sale | 4,500 | $23.01 | $103,532.85 | filing |
| 2026-04-15 | BCAX | Bicara Therapeutics Inc. | Option exercise | 8,000 | $3.79 | $30,318.40 | filing |
| 2026-03-16 | BCAX | Bicara Therapeutics Inc. | Sale | 8,000 | $19.66 | $157,256.80 | filing |
| 2026-03-16 | BCAX | Bicara Therapeutics Inc. | Sale | 4,500 | $19.66 | $88,456.95 | filing |
| 2026-03-16 | BCAX | Bicara Therapeutics Inc. | Option exercise | 8,000 | $3.79 | $30,318.40 | filing |
| 2026-03-03 | BCAX | Bicara Therapeutics Inc. | Sale | 12,892 | $18.16 | $234,158.69 | filing |
| 2026-03-03 | BCAX | Bicara Therapeutics Inc. | Sale | 4,500 | $18.16 | $81,733.95 | filing |
| 2026-03-03 | BCAX | Bicara Therapeutics Inc. | Option exercise | 12,892 | $3.79 | $48,858.10 | filing |
| 2026-02-25 | BCAX | Bicara Therapeutics Inc. | Sale | 3,108 | $18.04 | $56,066.77 | filing |
| 2026-02-25 | BCAX | Bicara Therapeutics Inc. | Option exercise | 3,108 | $3.79 | $11,778.70 | filing |
| 2026-02-25 | BCAX | Bicara Therapeutics Inc. | Sale | 523 | $18.04 | $9,434.66 | filing |
| 2026-01-22 | BCAX | Bicara Therapeutics Inc. | Sale | 3,828 | $18.10 | $69,295.99 | filing |
| 2026-01-15 | BCAX | Bicara Therapeutics Inc. | Sale | 149 | $18.02 | $2,684.98 | filing |
| 2025-12-26 | BCAX | Bicara Therapeutics Inc. | Option exercise | 25,000 | $4.44 | $110,922.50 | filing |
| 2025-12-15 | BCAX | Bicara Therapeutics Inc. | Sale | 8,000 | $18.68 | $149,470.40 | filing |
| 2025-12-15 | BCAX | Bicara Therapeutics Inc. | Sale | 4,500 | $18.68 | $84,077.10 | filing |
| 2025-12-15 | BCAX | Bicara Therapeutics Inc. | Option exercise | 8,000 | $3.79 | $30,318.40 | filing |
| 2025-11-21 | BCAX | Bicara Therapeutics Inc. | Sale | 8,000 | $18.05 | $144,376.00 | filing |
| 2025-11-21 | BCAX | Bicara Therapeutics Inc. | Sale | 4,500 | $18.05 | $81,211.50 | filing |
| 2025-11-21 | BCAX | Bicara Therapeutics Inc. | Option exercise | 8,000 | $3.79 | $30,318.40 | filing |
| 2025-10-15 | BCAX | Bicara Therapeutics Inc. | Sale | 8,000 | $18.16 | $145,243.20 | filing |
| 2025-10-15 | BCAX | Bicara Therapeutics Inc. | Sale | 4,500 | $18.16 | $81,699.30 | filing |
| 2025-10-15 | BCAX | Bicara Therapeutics Inc. | Option exercise | 8,000 | $3.79 | $30,318.40 | filing |
| 2025-10-07 | BCAX | Bicara Therapeutics Inc. | Sale | 8,000 | $18.06 | $144,472.80 | filing |
| 2025-10-07 | BCAX | Bicara Therapeutics Inc. | Sale | 2,900 | $18.06 | $52,371.39 | filing |
| 2025-10-07 | BCAX | Bicara Therapeutics Inc. | Option exercise | 8,000 | $3.79 | $30,318.40 | filing |
| 2025-10-06 | BCAX | Bicara Therapeutics Inc. | Sale | 24,000 | $18.06 | $433,332.00 | filing |
| 2025-10-06 | BCAX | Bicara Therapeutics Inc. | Sale | 15,600 | $18.06 | $281,665.80 | filing |
| 2025-10-06 | BCAX | Bicara Therapeutics Inc. | Option exercise | 24,000 | $3.79 | $90,955.20 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.